AT1 8.70% 2.1¢ atomo diagnostics limited

AT1 FY21 - General Discussion + FA, page-1131

  1. 521 Posts.
    lightbulb Created with Sketch. 93
    Don't think we still selling much to NG biotech, and the Australian market is tiny
    So this quarterly is basically about how the other two areas have grown...
    We'll find out soon enough, not expecting much, would accept a flat quarter. But absolutely do not want to see revenue goes backwards, that would be terrible for us holders
 
watchlist Created with Sketch. Add AT1 (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.